Lifeboat Foundation

“The Rejuvenome Project was launched to target these bottlenecks,” said Nicholas Schaum, PhD, Scientific Director at the Astera Institute. “We hope to do that by characterising treatments and regimens, both established and newly invented, for which we have reason to believe improve health and longevity.”

Previously, Schaum worked as a researcher at Stanford University, California, in conjunction with the Chan Zuckerberg BioHub. He organised dozens of labs and hundreds of researchers into a consortium that produced cell atlases, to characterise aging tissues in mice. These cell atlases became the foundation for Schaum’s further studies into whole-organ aging and single-cell parabiosis.

The Rejuvenome Project is expected to be complete in 2028. All wet lab operations will be centred at Buck, while the dry lab computational aspects will reside at the Astera Institute.

Circa 2019 😀

Because they can process massive amounts of data, computers can perform analytical tasks that are beyond human capability. Google, for instance, is using its computing power to develop AI algorithms that construct two-dimensional CT images of lungs into a three-dimensional lung and look at the entire structure to determine whether cancer is present. Radiologists, in contrast, have to look at these images individually and attempt to reconstruct them in their heads. Another Google algorithm can do something radiologists cannot do at all: determine patients’ risk of cardiovascular disease by looking at a scan of their retinas, picking up on subtle changes related to blood pressure, cholesterol, smoking history and aging. “There’s potential signal there beyond what was known before,” says Google product manager Daniel Tse.

The Black Box Problem

Continue reading “Rise of Robot Radiologists” »

I am pleased to share our most recent video on the “Dementia Safety Study” funded by Maximum Life Foundation and run by IHS, in which BioViva did the data analysis. This treatment shows promise for the millions of people who have dementia today. Though not a cure, it is a step in the right direction.

Can gene therapy delay or reverse Alzheimer’s and other dementias?

Continue reading “Human Dementia Study: BioViva Analyzes the Data” »

“Hubble is the only telescope that has the kind of temporal coverage and spatial resolution that can capture Jupiter’s winds in this much detail”

Over the past 100 years, however, the cyclone has been dwindling, but recent observations with Hubble show that the wind speeds may be picking up again. Is this just temporary, or will the storm return to its former glory?

Continue reading “‘No one has ever seen this before’: Jupiter’s Great Red Spot is speeding up” »

We have achieved strong, fast, power-dense, high-efficiency, biomimetic, soft, safe, clean, organic and affordable robotic technology. Dumbbell weights 7 kg (15,6 lbs) 0 forearm with hand only 1 kg (2,2 lbs).

This artificial muscles robotic arm is operated by water and consumes 200W at peak. We invent and produce portable power supply and our own electro-hydraulic mini valves to have complete controllability of speed contraction and compress the whole powering system (for a full body) inside humanlike robot torso.

Continue reading “Artificial Muscles Robotic Arm Full Range of Motion + Static Strength Test (V11)” »

Science, Technology & Protocols For Healthy Longevity And Sustainable Health — Joanna Bensz, Founder and CEO, Longevity Center & International Institute of Longevity (IIOL), joins me on Progress, Potential, And Possibilities Geopolitical Intelligence Services #Health #Wellness #Aging #Longevity #JoannaBensz #PrinceMichaelOfLiechtenstein

Joanna Bensz is Founder and CEO of Longevity Center (https://longevity-center.eu/), a boutique preventive health and longevity medical center, that focuses on scientifically and medically advanced technologies and protocols for healthy longevity and sustainable health.

Continue reading “Joanna Bensz — Founder and CEO, Longevity Center And International Institute of Longevity (IIOL)” »

One explanation for this could be the degree of efficiency of each organism’s response to the damage sustained by its cells during its life, which eventually causes them to age. In relation to this, researchers at the Universitat Oberta de Catalunya (UOC) and the University of Leicester (United Kingdom) have developed a new method to remove old cells from tissues, thus slowing down the aging process.

The longevity industry — startups trying to make people live longer or even forever, basically — tends to attract charlatans and scandal.

But a terrific feature story in New Statesman makes the case that a handful of ventures in the space are finally starting to hone in on some compelling ideas that might eventually provide modest or even radical life extension.

“I’m confident we’ll have an aging drug by the time it’s relevant for me,” 27-year-old Celine Halioua, a PhD dropout who now works at the anti-aging startup Loyal, who predicted that such a drug could become available “within a decade.”

The Co-founder of Formic Ventures, Michael Antonov, is using logic and innovation to drive the longevity sector forward.